Program for the 2022 Hematology and Oncology Best Practices Conference Dates: 2022 August 11–18
The most thorough board review available for doctors looking to renew their knowledge of medical oncology and hematology standards of care or who are getting ready to take the certification tests in these fields.

TARGET PUBLIC
This course is perfect for medical professionals who want a thorough study of medical oncology and hematology standards of care, as well as those who are getting ready to take the Hematology and Oncology certification tests.

PURPOSE OF LEARNING
Upon completion of the Hematology and Oncology Best Practices course, the accomplished student will possess the following abilities:

Blood and Transfusion

Recognize current clinical developments as well as established knowledge in the fields of immunohematology, bone marrow transplantation, and hematopoietic growth factors.
Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
Understand blood and marrow morphology and hematopathology
Understand red cell disorders
Hematologic Cancers

Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
Identify strategies for taking the board examinations
Cancer

Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
Understand the fundamentals of treating genito-urinary cancers, including gynecologic cancers.
Determine the most recent developments regarding lung, breast, and gastrointestinal tract cancers.
Understand the fundamentals of recent advancements in cancer biologic therapy.
Contend with complexity of HIV-related malignancies
COURSE OVERVIEW
Sessions in Hematology:

Day 1: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure and Sickle Cell Disease Overview
Day 2: Clotting and Bleeding Disorders
Day 3: TTP, HUS, DIC, HIT, ABO Incompatibility, Hematopoietic Transplantation and Hematologic Complications of Pregnancy
Hematologic Cancers Sessions:

Day 4: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
Day 5: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology
Medical Oncology Sessions:

Day 6: Breast Cancer, Lung Cancer, and Neuro-Oncology
Day 7: Renal Cell, Prostate, Bladder, Testicular, Ovarian and Endometrial Tumors
Day 8: GI Oncology, Mesothelioma and Sarcomas

See also: